Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomed-Warszawa, originally established as the Central Laboratory of Sera and Vaccines in Warsaw, was a prominent Polish manufacturer of immunobiological preparations. Founded in 1945, the company specialized in the production of vaccines, human sera, and probiotics, playing a critical role in Poland's public health infrastructure. Its most recognizable product, the probiotic Lakcid, remains a staple in the Polish market for treating intestinal flora disturbances. In 2010, the company was acquired by Polfa Warszawa, integrating its specialized manufacturing capabilities into the Polpharma Group. Today, the Warsaw facility continues to serve as a key site for biological production, maintaining the legacy of one of Poland's oldest biotech institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Central Laboratory of Sera and Vaccines in Warsaw.